Synapse Financial vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Synapse Financial

ChallengerEmbedded Finance

Banking-as-a-Service

Banking-as-a-service platform for fintech companies to offer deposit accounts and payments. San Francisco CA, raised $50M+. Note: filed for bankruptcy in 2024; serves as industry reference.

About

Synapse Financial was a prominent banking-as-a-service platform that provided fintech companies with the infrastructure to offer FDIC-insured deposit accounts, debit cards, and payment services through partnerships with sponsor banks. Founded in 2014 and headquartered in San Francisco, California, the company raised over $50 million in funding and at its peak processed billions in transaction volume for dozens of fintech customers. Synapse occupied a significant position in the early BaaS industry by enabling a new generation of fintech neobanks and embedded finance products.\n\nSynapse's platform offered APIs covering account opening, direct deposit, ACH transfers, debit card issuance, and compliance services. Fintech customers including Copper, Juno, and Yotta built their consumer banking products on top of Synapse's bank partner network. The company provided a technology abstraction layer that allowed fintechs to access banking infrastructure without negotiating their own bank sponsorship agreements.\n\nIn 2024, Synapse filed for bankruptcy following a breakdown in its financial reconciliation processes with bank partners, triggering a regulatory and legal crisis that left end-user customer funds in dispute. The Synapse collapse became a landmark event in the BaaS industry, prompting increased regulatory scrutiny of fintech-bank middleware relationships and accelerating a consolidation toward direct BaaS relationships and more heavily capitalized intermediaries. The episode reshaped how regulators, banks, and fintechs approach ledger reconciliation and custodial fund safeguarding in embedded banking.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.